Free Trial

West Pharmaceutical Services (WST) Competitors

West Pharmaceutical Services logo
$334.26 +3.69 (+1.12%)
(As of 12/17/2024 ET)

WST vs. COO, ALGN, MMSI, HAE, XRAY, ICUI, QDEL, NEOG, STAA, and CERS

Should you be buying West Pharmaceutical Services stock or one of its competitors? The main competitors of West Pharmaceutical Services include Cooper Companies (COO), Align Technology (ALGN), Merit Medical Systems (MMSI), Haemonetics (HAE), DENTSPLY SIRONA (XRAY), ICU Medical (ICUI), QuidelOrtho (QDEL), Neogen (NEOG), STAAR Surgical (STAA), and Cerus (CERS). These companies are all part of the "health care supplies" industry.

West Pharmaceutical Services vs.

West Pharmaceutical Services (NYSE:WST) and Cooper Companies (NASDAQ:COO) are both large-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, community ranking, valuation, dividends, institutional ownership, risk, earnings, analyst recommendations and media sentiment.

In the previous week, Cooper Companies had 3 more articles in the media than West Pharmaceutical Services. MarketBeat recorded 30 mentions for Cooper Companies and 27 mentions for West Pharmaceutical Services. West Pharmaceutical Services' average media sentiment score of 0.95 beat Cooper Companies' score of 0.58 indicating that West Pharmaceutical Services is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
West Pharmaceutical Services
12 Very Positive mention(s)
2 Positive mention(s)
10 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cooper Companies
14 Very Positive mention(s)
0 Positive mention(s)
6 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

West Pharmaceutical Services has a beta of 1.01, indicating that its share price is 1% more volatile than the S&P 500. Comparatively, Cooper Companies has a beta of 0.97, indicating that its share price is 3% less volatile than the S&P 500.

West Pharmaceutical Services currently has a consensus price target of $437.75, suggesting a potential upside of 31.00%. Cooper Companies has a consensus price target of $117.00, suggesting a potential upside of 23.70%. Given West Pharmaceutical Services' stronger consensus rating and higher possible upside, analysts clearly believe West Pharmaceutical Services is more favorable than Cooper Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
West Pharmaceutical Services
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80
Cooper Companies
0 Sell rating(s)
3 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.75

Cooper Companies received 356 more outperform votes than West Pharmaceutical Services when rated by MarketBeat users. Likewise, 66.38% of users gave Cooper Companies an outperform vote while only 55.81% of users gave West Pharmaceutical Services an outperform vote.

CompanyUnderperformOutperform
West Pharmaceutical ServicesOutperform Votes
264
55.81%
Underperform Votes
209
44.19%
Cooper CompaniesOutperform Votes
620
66.38%
Underperform Votes
314
33.62%

West Pharmaceutical Services has higher earnings, but lower revenue than Cooper Companies. Cooper Companies is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
West Pharmaceutical Services$2.95B8.20$593.40M$6.7449.58
Cooper Companies$3.90B4.85$392.30M$1.9548.50

93.9% of West Pharmaceutical Services shares are held by institutional investors. Comparatively, 24.4% of Cooper Companies shares are held by institutional investors. 0.5% of West Pharmaceutical Services shares are held by insiders. Comparatively, 2.0% of Cooper Companies shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

West Pharmaceutical Services has a net margin of 17.37% compared to Cooper Companies' net margin of 10.07%. West Pharmaceutical Services' return on equity of 18.41% beat Cooper Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
West Pharmaceutical Services17.37% 18.41% 13.74%
Cooper Companies 10.07%9.38%6.09%

Summary

West Pharmaceutical Services beats Cooper Companies on 12 of the 18 factors compared between the two stocks.

Get West Pharmaceutical Services News Delivered to You Automatically

Sign up to receive the latest news and ratings for WST and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WST vs. The Competition

MetricWest Pharmaceutical ServicesSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$24.20B$4.38B$5.11B$19.59B
Dividend Yield0.25%44.87%4.81%3.50%
P/E Ratio49.5824.87134.4543.96
Price / Sales8.2046.841,253.7117.42
Price / Cash32.4244.2040.3121.72
Price / Book8.507.234.885.45
Net Income$593.40M$13.57M$117.66M$986.21M
7 Day Performance4.67%-3.05%14.33%-2.26%
1 Month Performance6.26%3.05%17.31%1.16%
1 Year Performance-6.71%54.01%36.11%16.24%

West Pharmaceutical Services Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WST
West Pharmaceutical Services
4.9723 of 5 stars
$334.26
+1.1%
$437.75
+31.0%
-6.7%$23.94B$2.88B49.5910,600
COO
Cooper Companies
2.8215 of 5 stars
$95.14
+0.3%
$117.00
+23.0%
+4.1%$18.99B$3.90B48.6415,000Short Interest ↑
ALGN
Align Technology
4.7658 of 5 stars
$232.25
-1.3%
$271.20
+16.8%
-10.3%$17.34B$3.96B40.1721,610
MMSI
Merit Medical Systems
4.4434 of 5 stars
$102.90
+0.1%
$105.09
+2.1%
+38.3%$6.00B$1.33B50.476,950
HAE
Haemonetics
4.6739 of 5 stars
$82.28
+1.3%
$108.78
+32.2%
-8.0%$4.13B$1.36B33.693,657Positive News
XRAY
DENTSPLY SIRONA
4.8947 of 5 stars
$20.03
+1.6%
$28.40
+41.8%
-44.2%$3.98B$3.90B-9.5315,000Dividend Announcement
Analyst Forecast
ICUI
ICU Medical
4.6049 of 5 stars
$161.28
-0.2%
$199.67
+23.8%
+58.1%$3.95B$2.34B-35.3714,000
QDEL
QuidelOrtho
4.2272 of 5 stars
$42.68
+3.2%
$53.43
+25.2%
-39.4%$2.87B$3.00B-1.577,100Gap Up
NEOG
Neogen
3.5759 of 5 stars
$12.03
-1.0%
$17.50
+45.5%
-37.5%$2.61B$912.20M-110.452,640
STAA
STAAR Surgical
4.6411 of 5 stars
$24.53
-1.3%
$42.83
+74.6%
-23.9%$1.21B$322.42M56.501,115
CERS
Cerus
2.9613 of 5 stars
$1.82
+6.1%
$3.63
+99.7%
-21.0%$337.07M$176.23M-15.55625News Coverage
Positive News

Related Companies and Tools


This page (NYSE:WST) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners